Bendamustine in relapsed or refractory chronic lymphocytic leukemia.
Ferrajoli
Alessandra
A
Department of Leukaemia, The University of Texas, MD Anderson Cancer Center, Houston, USA. aferrajo@mdanderson.org
D000069461:Bendamustine Hydrochloride; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000517:prevention & control; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D055502:Secondary Prevention
D009588:Nitrogen Mustard Compounds; D000069461:Bendamustine Hydrochloride